Table 1 Clinical characteristics of study population
From: The use of Transcollation Technology for Video-Assisted Thoracic Surgery lobectomy
Variables | All patients | TT Group | TE Group | p |
|---|---|---|---|---|
Number | 53 | 24 | 29 | – |
Age | 63.7 ± 4.9 | 64.2 ± 3.9 | 62.1 ± 4.5 | 0.74 |
Gender (male) | 35 (66%) | 16 (67%) | 19 (65%) | 0.85 |
BMI | 25 ± 8.1 | 24.9 ± 2.8 | 25.1 ± 3.1 | 0.65 |
Charlson index | 2.89 ± 0.7 | 2.8 ± 0.3 | 2.77 ± 0.3 | 0.69 |
Lung Function | ||||
• ppoFEV1% | 85.9 ± 3.9 | 85 ± 4.9 | 86 ± 3.5 | 0.87 |
• ppoDLCO% | 82.7 ± 6.9 | 81.7 ± 8.3 | 82 ± 6.5 | 0.75 |
Pathologic Stage | ||||
• I | 33 (62%) | 15 (61%) | 18 (69%) | 0.82 |
• II | 11 (21%) | 5 (31%) | 6 (22%) | 0.98 |
• III | 9 (17%) | 4 (8%) | 5 (9%) | 0.95 |
Histology | ||||
• Adenocarcinoma | 40 (75%) | 19 (79%) | 21 (72%) | 0.57 |
• Squamous cell carcinoma | 11 (21%) 2 (4%) | 5 (21%) 0 | 6 (21%) 2 (7%) | 0.98 0.19 |
• Others | ||||
Surgery | ||||
• Uniportal- VATS | 25 (47%) | 11 (46%) | 14 (48%) | 0.86 |
• Triportal VATS | 28 (53%) | 13 (54%) | 15 (52%) | 0.86 |